盐酸万古霉素, 植物素级

盐酸万古霉素, 植物素级

CAS Number: 1404-93-9 Molecular Formula: C66H75Cl2N9O24-HCl Molecular Weight: 1485.70

Beilstein Registry Number: 3704657

SKU 02195540-CF
CN¥0.00
In Stock
Request a quote
Description

Product Description

A glycopeptide antibiotic active against gram-positive bacteria. Used to block bacterial cell wall synthesis at the level of peptidoglycan biosynthesis by inhibiting incorporation of terminal D-Ala-D-Ala moieties of the NAM/NAG-peptides. Suitable for plant cell culture.

Application Notes

Vancomycin is indicated for the treatment of serious, life-threatening infections by Gram-positive bacteria that are unresponsive to other less-toxic antibiotics. In particular, vancomycin should not be used to treat methicillin-sensitive Staphylococcus aureus because it is inferior to penicillins such as nafcillin.Vancomycin, from Streptomyces orientalis, is used for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. It is used to block bacterial cell wall biosynthesis at the level of peptidoglycan biosynthesis. It is widely studied in cancer patients.

Usage Statement

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

Key Applications

Antibiotic

Specifications
SKU 02195540-CF
Application Notes Vancomycin is indicated for the treatment of serious, life-threatening infections by Gram-positive bacteria that are unresponsive to other less-toxic antibiotics. In particular, vancomycin should not be used to treat methicillin-sensitive Staphylococcus aureus because it is inferior to penicillins such as nafcillin.Vancomycin, from Streptomyces orientalis, is used for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. It is used to block bacterial cell wall biosynthesis at the level of peptidoglycan biosynthesis. It is widely studied in cancer patients.
Base Catalog Number 195540
Beilstein Registry Number 3704657
Biochemical Physiological Actions Glycopeptide antibiotic Mode of action: Used to block bacterial cell wall biosynthesis at the level of peptidoglycan biosynthesis by inhibiting incorporation of terminal D-alanyl-D-alanine moieties of the NAM/NAG-peptides.Antimicrobial spectrum: Gram-positive bacteria
CAS # 1404-93-9
Format Powder
Hazard Statements H317
Molecular Formula C66H75Cl2N9O24-HCl
Molecular Weight 1485.70
Personal Protective Equipment dust mask, Eyeshields, Faceshields, Gloves
Potency ~1000 µg/mg
RTECS Number YW4380000
Safety Symbol GHS07
Source Streptomyces orientalis
Usage Statement Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.